SBC Medical Group Holdings Incorporated
SBC
$4.11
$0.092.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 205.42M | 223.34M | 217.54M | 205.44M | 193.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 205.42M | 223.34M | 217.54M | 205.44M | 193.54M |
| Cost of Revenue | 49.37M | 57.80M | 61.73M | 57.13M | 56.24M |
| Gross Profit | 156.05M | 165.55M | 155.80M | 148.31M | 137.30M |
| SG&A Expenses | 84.59M | 96.12M | 80.10M | 84.31M | 86.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 195.20K | -771.40K | -681.60K | -670.70K | -578.70K |
| Total Operating Expenses | 120.05M | 133.77M | 121.77M | 121.39M | 122.88M |
| Operating Income | 85.36M | 89.58M | 95.76M | 84.04M | 70.66M |
| Income Before Tax | 73.46M | 90.96M | 98.92M | 88.51M | 73.58M |
| Income Tax Expenses | 26.77M | 36.59M | 39.33M | 37.61M | 35.02M |
| Earnings from Continuing Operations | 46.69 | 54.37 | 59.59 | 50.89 | 38.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -75.70K | 45.60K | 345.80K | 1.23M | 809.30K |
| Net Income | 46.61M | 54.42M | 59.94M | 52.13M | 39.37M |
| EBIT | 85.36M | 89.58M | 95.76M | 84.04M | 70.66M |
| EBITDA | 89.16M | 95.00M | 103.46M | 94.51M | 82.91M |
| EPS Basic | 4.78 | 4.87 | 4.93 | 3.94 | 1.58 |
| Normalized Basic EPS | 4.38 | 4.44 | 4.49 | 3.78 | 1.87 |
| EPS Diluted | 4.84 | 4.87 | 4.93 | 3.94 | 1.58 |
| Normalized Diluted EPS | 4.38 | 4.44 | 4.49 | 3.78 | 1.87 |
| Average Basic Shares Outstanding | 213.75M | 205.19M | 204.28M | 204.28M | 196.33M |
| Average Diluted Shares Outstanding | 213.75M | 205.19M | 204.28M | 204.28M | 196.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |